SCHEMBL23979550

SCHEMBL23979550

CNC(C)c1cccc2nccc(Cl)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.38
SLC6A4 P31645 5/20 0.38
KCNH2 Q12809 3/20 0.38
PARP1 P09874 1/20 0.34
AURKA O14965 1/20 0.32
AURKB Q96GD4 1/20 0.32
CYP2C19 P33261 1/20 0.32
CYP2D6 P10635 2/20 0.32
PIK3CD O00329 2/20 0.32
PIK3R1 P27986 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
NFKB1 P19838 1/20 0.32
PNMT P11086 1/20 0.32
KRAS P01116 2/20 0.32
SOS1 Q07889 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
XIAP P98170 1/20 0.31
BIRC2 Q13490 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23979801 0.83 ELANE (0.39) PARP1CYP2C19CYP2D6CYP1A2CYP3A4
SCHEMBL23479216 0.77 PARP1 (0.41) PARP1CYP2C19CYP2D6CYP1A2CYP3A4
SCHEMBL29404834 0.73 PARP1 (0.50) PARP1AURKAAURKBCYP2C19CYP1A2
SCHEMBL6465602 0.73 PARP1 (0.50) PARP1AURKAAURKBCYP2C19CYP1A2
SCHEMBL8603889 0.71 PARP1 (0.44) PARP1AURKAAURKBCYP2C19CYP1A2
SCHEMBL14614619 0.70 NCF1 (0.44) CYP2C19CYP2D6CYP1A2CYP3A4KRAS
SCHEMBL27010719 0.69 ELANE (0.43) CYP2C19CYP2D6CYP1A2CYP3A4ALDH1A1
SCHEMBL8284240 0.69 CYP2D6 (0.59) HTR2ASLC6A4KCNH2CYP2D6CYP1A2
SCHEMBL15983778 0.68 HTR2A (0.51) HTR2ASLC6A4KCNH2CYP2C19CYP2D6
SCHEMBL2400753 0.68 HTR2A (0.51) HTR2ASLC6A4KCNH2CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219072-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 (CN) 2021-11-04 WO disclosed